Elicera Therapeutics AB
ELIC SE0015382080
ICB 2010 : Health Care / Health CareAnnual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-19% | -29% | 23% | -65% | 13% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Jamal El Mosleh CEO |
6.59 SEK |
20,000 Sold |
131,800 SEK |
27/05/2025 | 27/05/2025 |
Jamal El Mosleh CEO |
7.06 SEK |
25,000 Sold |
176,500 SEK |
27/05/2025 | 26/05/2025 |
Jamal El Mosleh CEO |
6.51 SEK |
102,500 Sold |
667,275 SEK |
27/05/2025 | 23/05/2025 |
Jamal El Mosleh CEO |
6.30 SEK |
237,500 Sold |
1,496,250 SEK |
27/05/2025 | 22/05/2025 |
Jamal El Mosleh CEO |
1.00 SEK |
50,000 Bought |
50,000 SEK |
26/04/2024 | 25/04/2024 |
Jamal El Mosleh CEO |
1.28 SEK |
2,687,000 Bought |
3,439,360 SEK |
21/03/2024 | 20/03/2024 |
Jamal El Mosleh CEO |
1.28 SEK |
2,687,000 Sold |
3,439,360 SEK |
21/03/2024 | 20/03/2024 |
Agneta Edberg CB |
4.30 SEK |
12,791 Bought |
55,001 SEK |
06/07/2021 | 05/07/2021 |
Di Yu DIR |
4.30 SEK |
12,100 Bought |
52,030 SEK |
05/07/2021 | 05/07/2021 |
Jan Zetterberg DIR |
4.30 SEK |
14,000 Bought |
60,200 SEK |
05/07/2021 | 05/07/2021 |